V. Santora

发表

Discovery and evaluation of dual CDK1 and CDK2 inhibitors.

Juan Leal, Richard Kendall, T. Bush, 2006, Cancer research.

A new family of H3 receptor antagonists based on the natural product Conessine.

V. Santora, J. Knudsen, C. Sage, 2008, Bioorganic & medicinal chemistry letters.

Novel H3 receptor antagonists with improved pharmacokinetic profiles.

V. Santora, John Covel, Albert S. Ren, 2008, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of a series of pyrrolo[3,2-d]pyrimidine derivatives and related compounds as neuropeptide Y5 receptor antagonists.

N. Chen, Z. Chen, V. Santora, 2000, Journal of medicinal chemistry.

Rapid identification of a novel phosphodiesterase 7B tracer for receptor occupancy studies using LC─MS/MS

V. Santora, Mi Chen, T. Keenan, 2020, Neurochemistry International.

Complexation of Creatinine by Synthetic Receptors

V. Santora, Anand Kumar, D. Beckles, 1995 .

Cyclobutenone-Based Syntheses of Polyquinanes and Bicyclo[6.3.0]undecanes by Tandem Anionic Oxy-Cope Reactions. Total Synthesis of (+/-)-Precapnelladiene.

J. Macdougall, V. Santora, S. Verma, 1998, The Journal of organic chemistry.

Tandem Oxy-Cope-Transannular Ring Closure Route to Polyquinanes

V. Santora, H. W. Moore, 1995 .

Complexation of benzamidinium by a new family of artificial receptors

V. Santora, T. Bell, 1992 .

Azetidine-based selective glycine transporter-1 (GlyT1) inhibitors with memory enhancing properties.

Michael R. Kennedy, Kiev S. Ly, Marco Peters, 2020, Bioorganic & medicinal chemistry letters.

Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors.

V. Viswanadhan, T. Osslund, D. Powers, 2007, Bioorganic & medicinal chemistry.

Design and Synthesis of Novel and Selective Glycine Transporter-1 (GlyT1) Inhibitors with Memory Enhancing Properties.

Michael R. Kennedy, Kiev S. Ly, D. M. Chung, 2018, Journal of medicinal chemistry.